Dr. Samuel Unzek Freiman, MD

Dr. Unzek Freiman practices at Banner Alzheimer's Institute in Sun City, Arizona.

Dr. Unzek Freiman's NPI, 1548442577, was assigned on November 30, 2007. Dr. Unzek Freiman holds Arizona license 43097.

Dr. Unzek Freiman's primary practice is Banner Alzheimer's Institute, at 10515 W Santa Fe Dr, Sun City, AZ 85351 in Maricopa County. The practice phone is (602) 747-4000.

Dr. Unzek Freiman's primary practice is Banner Alzheimer's Institute in Sun City, Arizona. Dr. Unzek Freiman is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Unzek Freiman to 1 more hospital, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Unzek Freiman practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Unzek Freiman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Unzek Freiman's licenses on file in 2 states: Arizona and Ohio.

CMS data shows 1,316 Medicare services from Dr. Unzek Freiman across 20 procedure codes in 2024, for 733 Medicare patients. Medicare paid $50,046 for them.

CMS counts 733 Medicare patients who saw Dr. Unzek Freiman in 2024. The largest group is 65 to 74, with 313 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Unzek Freiman's median patient age at 71, with 46% women.

In 2024, Dr. Unzek Freiman wrote 510 Medicare Part D claims for 120 patients. 81% of them were for generic drugs. CMS names the drug for 398 of them, across 15 drugs with 11 or more claims each, at $94,380 in total drug cost. In 2023, CMS named 360 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Unzek Freiman for performance year 2024, reported as part of a group. Dr. Unzek Freiman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Unzek Freiman as offering telehealth.

Dmand AI links 1 paper to Dr. Unzek Freiman in 2012. Dr. Unzek Freiman's most frequent co-author is Anil Pandit, MD.

CMS Open Payments shows 19 general payments to Dr. Unzek Freiman from 5 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $361.